Results will soon be announced for the Disease Team Research Awards Competition of the California Institute for Regenerative Medicine (CIRM). These awards will support multi-disciplinary teams of scientists in pursuit of therapies for specific diseases. See:
The Lucky 11 and $167 Million in Stem Cell Research Cash, David Jensen,
California Stem Cell Report, October 23, 2009. First two paragraphs:
The California stem cell agency has pinpointed 11 likely winners of grants and loans up to $20 million each in the agency's ambitious disease team round, which was once projected at $210 million.
The awards are scheduled to be formally approved next week by the CIRM board of directors at a two-day meeting in Los Angeles at the Luxe Hotel. CIRM's Grants Working Group decided earlier that 11 proposals merited funding. The CIRM board almost never rejects a recommendation for funding by its reviewers.
Comment: Participation in the Disease Team Research Awards program is the first initiative launched by the Cancer Stem Cell Consortium (CSCC), in collaboration with CIRM. This is an international collaboration to advance cancer stem cell research, involving both Canadian and Californian scientists. See this previous post:
CIRM/CSCC Joint Announcement: Disease Teams Awards, October 23, 2008.
Posts
There's been an advisory to news outlets about the CIRM news conference on October 28. See: CIRM Hopes for Big Media Splash on Disease Team Grants, California Stem Cell Report, October 26, 2009, and: CIRM Disease Team Media Advisory 10-26-09.
ReplyDelete